Filter
1688
Filtered Results: 1688
Text search:
drug
formulations
Featured
Recommendations
184
New Publications
556
Language
Document type
No document type
1065
Guidelines
285
Studies & Reports
181
Manuals
63
Strategic & Response Plan
40
Training Material
20
Fact sheets
20
Situation Updates
6
Infographics
4
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
102
Kenya
71
Uganda
53
Tanzania
42
Global
39
Malawi
37
Nepal
36
Ethiopia
36
South Africa
34
Liberia
33
Sierra Leone
29
Nigeria
28
Ghana
27
Zambia
27
Rwanda
26
Bangladesh
23
Philippines
22
Namibia
22
Zimbabwe
21
Myanmar / Burma
21
Latin America and the Carribbean
19
Western and Central Europe
19
Cambodia
17
Africa
16
Botswana
12
Lesotho
11
Senegal
11
Indonesia
10
Eswatini/ Swaziland
10
South–East Asia Region
9
Cameroon
8
Haiti
7
Congo, Democratic Republic of
7
Burkina Faso
6
Eastern Europe
6
Ukraine
5
Syria
5
Russia
5
Benin
4
Albania
4
Asia
4
Pakistan
4
Tajikistan
3
Thailand
3
Mozambique
3
Eastern Europe and Central Asia
3
Georgia
3
South Sudan
3
Madagascar
3
North Macedonia
2
Iran
2
Afghanistan
2
Guinea
2
USA
2
Middle East and North Africa
2
Western Pacific Region
2
Gabon
2
United Kingdom
2
East and Southern Africa
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Lebanon
2
Vietnam
2
Sri Lanka
2
Sudan
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Peru
1
Malaysia
1
Morocco
1
Venezuela
1
Jordan
1
Ireland
1
Saudi Arabia
1
Paraguay
1
North America
1
Turkmenistan
1
Denmark
1
France
1
Tunisia
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Moldova
1
Yemen
1
Greece
1
Mali
1
Bhutan
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
746
Clinical Guidelines
249
Women & Child Health
77
Public Health
76
Key Resources
31
Capacity Building
25
Pharmacy & Technologies
25
Toolboxes
HIV
178
TB
167
Pharmacy
111
AMR
104
Mental Health
89
COVID-19
49
NTDs
37
NCDs
28
Rapid Response
26
Caregiver
26
Ebola
21
Refugee
16
Planetary Health
12
Disability
11
Global Health Education
8
Specific Hazards
6
Health Financing Toolbox
6
Conflict
6
Natural Hazards
5
Cholera
5
Polio
4
Social Ethics
3
Zika
3
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
This guideline provides evidence-based recommendations on parenting interventions for parents and caregivers of children aged 0–17 years that are designed to reduce child maltreatment and harsh parenting, enhance the parent–child relationship, and prevent poor mental health among parents and emo...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
The revision of the SRHR Policy is based on the results of the analysis of the implementation process of the past policy, which has provided evidence to
ensure that the revised policy is relevant and effective. The revision has also been done with the participation of all national stakeholders who ...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting, ...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
